Search

Your search keyword '"Rosenson R"' showing total 186 results

Search Constraints

Start Over You searched for: Author "Rosenson R" Remove constraint Author: "Rosenson R"
186 results on '"Rosenson R"'

Search Results

2. ARO-ANG3, an investigational RNAI therapeutic, decreases serum LDL-cholesterol, apolipoprotein B, and angiopoietin-like protein 3 in patients with homozygous familial hypercholesterolaemia

3. Recurrent atherosclerotic cardiovascular disease events preventable with guideline recommended lipid-lowering treatment following myocardial infarction

4. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

7. Underuse of Combination Pharmacotherapy for Management of Dyslipidaemia Versus Diabetes and Hypertension among Patients with Atherosclerotic Cardiovascular Disease (ASCVD): Insights from the Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD) Registry

11. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

12. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

13. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

14. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel

15. Aspirin

16. Evolocumab and clinical outcomes in patients with cardiovascular disease

22. Can LDL cholesterol be too low? Possible risks of extremely low levels

23. Can LDL cholesterol be too low? Possible risks of extremely low levels

25. Comparison of PCSK9 inhibitor evolocumab vs ezetimibe in statin-intolerant patients: Design of the goal achievement after utilizing an anti-PCSK9 antibody in statin-intolerant subjects 3 (GAUSS-3) trial

26. Can LDL cholesterol be too low? Possible risks of extremely low levels

30. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension

31. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

Catalog

Books, media, physical & digital resources